Farmacia e farmacoloxía
Servizo
![Foto de Farmacia e farmacoloxía](/img/noimage.png)
![Foto de Consiglio Nazionale delle Ricerche](/img/noimage_org.png)
Consiglio Nazionale delle Ricerche
Roma, ItaliaPublicacións en colaboración con investigadores/as de Consiglio Nazionale delle Ricerche (7)
2024
-
N-Adamantyl-1-alkyl-4-oxo-1,4-dihydroquinoline-3-carboxamide Derivatives as Fluorescent Probes to Detect Microglia Activation through the Imaging of Cannabinoid Receptor Subtype 2 (CB2R)
Journal of Medicinal Chemistry, Vol. 67, Núm. 13, pp. 11003-11023
2023
-
Antiviral Peptides Delivered by Chitosan-Based Nanoparticles to Neutralize SARS-CoV-2 and HCoV-OC43
Pharmaceutics, Vol. 15, Núm. 6
-
Biofunctionalization of 3D printed collagen with bevacizumab-loaded microparticles targeting pathological angiogenesis
Journal of Controlled Release, Vol. 360, pp. 747-758
-
Development of N-(1-Adamantyl)benzamides as Novel Anti-Inflammatory Multitarget Agents Acting as Dual Modulators of the Cannabinoid CB2 Receptor and Fatty Acid Amide Hydrolase
Journal of Medicinal Chemistry, Vol. 66, Núm. 1, pp. 235-250
-
N-adamantyl-anthranil amide derivatives: New selective ligands for the cannabinoid receptor subtype 2 (CB2R)
European Journal of Medicinal Chemistry, Vol. 248
2021
-
Synthesis and Biological Evaluation of Dantrolene-Like Hydrazide and Hydrazone Analogues as Multitarget Agents for Neurodegenerative Diseases
ChemMedChem, Vol. 16, Núm. 18, pp. 2807-2816
2008
-
1,3-Dialkyl-8-(hetero)aryl-9-OH-9-deazaxanthines as potent A2B adenosine receptor antagonists: Design, synthesis, structure-affinity and structure-selectivity relationships
Bioorganic and Medicinal Chemistry, Vol. 16, Núm. 22, pp. 9780-9789